Challenges and Advances through Polymeric Soft Nanoparticles

Samaneh Yousefi Adlsadabad,John W. Hanrahan,Ashok Kakkar

DOI: https://doi.org/10.3390/ijms25031739

IF: 5.6

2024-02-02

International Journal of Molecular Sciences

Abstract:Single-stranded messenger ribonucleic acid (mRNA) plays a pivotal role in transferring genetic information, and tremendous effort has been devoted over the years to utilize its transcription efficacy in therapeutic interventions for a variety of diseases with high morbidity and mortality. Lipid nanocarriers have been extensively investigated for mRNA delivery and enabled the rapid and successful development of mRNA vaccines against SARS-CoV-2. Some constraints of lipid nanocarriers have encouraged the development of alternative delivery systems, such as polymer-based soft nanoparticles, which offer a modular gene delivery platform. Such macromolecule-based nanocarriers can be synthetically articulated for tailored parameters including mRNA protection, loading efficacy, and targeted release. In this review, we highlight recent advances in the development of polymeric architectures for mRNA delivery, their limitations, and the challenges that still exist, with the aim of expediting further research and the clinical translation of such formulations.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The main problem this paper attempts to address is the challenges in mRNA delivery, particularly how to improve the stability and delivery efficiency of mRNA through polymeric soft nanoparticles. Specifically, the paper focuses on the following aspects:

1. **Challenges in mRNA Stability and Delivery**: mRNA is a single-stranded ribonucleic acid that, despite its great potential in gene therapy, has some inherent drawbacks. These include a large molecular weight and a negative charge, making cellular uptake difficult; its single-stranded structure makes it susceptible to degradation by ribonucleases in the extracellular matrix; and it may degrade in endosomes after entering the cell, preventing it from reaching the cytoplasm.

2. **Limitations of Existing Delivery Systems**: The most commonly used mRNA delivery systems currently are lipid nanoparticles (LNPs). Although LNPs have achieved significant success in the development of COVID-19 vaccines, they still have some issues, such as instability in biological media, off-target effects, and low drug loading efficiency. These problems limit the clinical application of mRNA therapies.

3. **Advantages and Prospects of Polymeric Soft Nanoparticles**: To overcome the aforementioned issues, researchers have begun exploring polymer-based soft nanoparticles as mRNA delivery carriers. These polymeric nanoparticles offer high designability and multifunctionality, allowing for efficient protection, high loading rates, and targeted release of mRNA through chemical modifications.

4. **Future Research Directions**: The paper also discusses the latest advancements, existing limitations, and future research directions of polymeric nanoparticles in mRNA delivery, aiming to accelerate further research and clinical translation of these delivery systems.

In summary, this paper aims to review the application of polymeric soft nanoparticles in mRNA delivery, explore their potential in addressing the limitations of existing delivery systems, and provide guidance for future research work.